Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 129Gastrointestinal 79Head & Neck 73Other solid neoplasm 70Gynecologic 62Tumor-Agnostic 25Genitourinary 24Breast 19Sarcoma 15Lymphoid 15Dermatologic 15CNS 11Endocrine 5Other hematologic neoplasm 2Other 1NET 1Myeloid 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1

Interventions

Metformin 2rosiglitazone-metformin combination 1mirabegron 1lorcaserin 1exemestane 1atezolizumab 1angiotensin I (1-7) 1Traumeel S 1Tirzepatide 1TIC10 compound 1Sodium Chloride 1Rosiglitazone 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Melphalan 1Leflunomide 1Hydroquinones 1Fish Oils 1Fibroblast Growth Factor 7 1Drug Therapy 1Docosahexaenoic Acids 1Cisplatin 1Cholestyramine Resin 1CBLB502 1Ascorbic Acid 1Acupuncture Therapy 1ART123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Cisplatin × Other × Clear all
NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡